SecBot SecBot
8-K ·Filed Nov 3, 2026

PROF

Profound Medical Corp.
NEUTRAL
Impact 4/10
Horizonmonths Processed13d 8h ago SEC0001104659-26-121980
8-K material event: Items 1.01
Actionable Insight • Neutral

The agreement is contingent on FDA clearance for TULSA-PRO with Cook Equipment, with a deadline of April 30, 2027. Monitor for FDA 510(k) clearance announcements and initial system placements through Cook's Copernicus program, which would signal the start of the 5-year term and potential revenue contribution.

DirectionNeutral
Confidencehigh
Horizonmonths

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+5
Entry
$7.16
T+0 close · Nov 3, 2026 · via day close
Latest settled
+9.64%
T+5 · $7.85 · next T+20 in 16d
Vs SPY
+10.55%
α at T+5
Latest observation
+7.27%
T+7 · FF3 residual α
  1. T+0 · Nov 4 $7.16entry
  2. T+1 · 12d ago −3.91%α +0.50% · $6.88
  3. T+5 · 6d ago +9.64%α +10.55% · $7.85
  4. T+8 · todayOpen
  5. T+20 · in 16d Pending
  6. T+60 · in 3mo Pending

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Profound Medical entered into a supply and distribution agreement with Cook Medical's iMRI Division, appointing Cook as a non-exclusive U.S. distributor of its TULSA-PRO system for use with Cook's iMRI suite equipment. The 5-year initial term begins upon FDA clearance for the Products with Cook Equipment, with a backstop of April 30, 2027 for Cook to terminate if clearance is not obtained. Profound retains direct recurring revenue from disposables and service contracts for systems sold through Cook, adding a new capital equipment channel alongside its existing Siemens Healthineers relationship.

Key Facts

  • Profound appointed Cook as a non-exclusive U.S. distributor of TULSA-PRO for use with Cook iMRI equipment
  • 5-year initial term begins upon FDA clearance for Products with Cook Equipment; Cook may terminate if clearance not obtained by April 30, 2027
  • Profound retains direct recurring revenue from single-use disposables and service contracts for systems sold through Cook
  • Profound may also sell directly to customers that bought Cook Equipment but not Products through Cook in a quarter
  • Parties will coordinate sales/marketing through a joint steering committee
  • Agreement complements Profound's existing co-sales agreement with Siemens Healthineers

Financial Impact

No financial terms disclosed; deal value, pricing, and minimum percentages redacted as confidential

revenue

Risk Factors

  • FDA clearance for TULSA-PRO with Cook Equipment is a condition precedent; if not obtained by April 30, 2027, Cook may terminate without liability
  • Minimum sales percentages are redacted; failure to meet them does not breach the agreement but allows Profound to appoint other distributors for Cook Equipment use
  • No binding commitment for future TULSA-PRO system configurations (.55T and 1.55T compatible systems)
  • document contains text addressed to automated readers

Market Snapshot

Exchange
Nasdaq
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
80% bullish (5 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001104659-26-121980
Document: tm2628889d1_8k.htm0001104659-26-121980
Document: tm2628889d1_ex99-1.htm0001104659-26-121980
Document: 0001104659-26-121980-index-headers.html0001104659-26-121980
Document: 0001104659-26-121980-index.html0001104659-26-121980
Document: 0001104659-26-121980.txt0001104659-26-121980

Track record

22 reports on PROF

Performance horizon

2 of 3 bullish or bearish reports moved the stock their way by T+20. Best: +25.61% at T+60 after the Mar 5, 2026 report. 3 of 4 went positive at some point.

Filters
  1. Nov 12, 20264d ago 8-K Neutral 3/10 Entry $7.44 Now $7.34 −1.34% settles Dec 11
  2. Nov 9, 20267d ago 8-K Neutral 2/10 Entry $7.34 Now $7.34 +0.00% settles Dec 8
  3. Nov 5, 202611d ago 8-K Bearish 5/10 Entry $7.21 Now $7.34 −1.80% settles Dec 7
  4. Nov 3, 202613d ago 8-K Neutral 4/10 Viewing Entry $7.16 Now $7.34 +2.51% settles Dec 3
  5. Oct 30, 202617d ago Press Release Neutral 4/10 Entry $6.57 Now $7.34 +11.72% settles Nov 30
  6. Oct 22, 202625d ago 8-K Neutral 2/10 Entry $5.56 Now $7.34 +32.01% settles Nov 20
  7. Oct 14, 20264w ago 8-K Neutral 3/10 Entry $6.62 to $7.68 Now $7.34 +10.88% ▲ +16.01% +18.57% vs SPY
  8. Oct 9, 20265w ago 8-K Neutral 3/10 Entry $6.90 to $7.01 Now $7.34 +6.38% ▲ +1.59% +7.15% vs SPY
  9. Oct 7, 20265w ago 8-K Bullish 7/10 Entry $6.91 to $7.16 Now $7.34 +6.22% ▲ +3.62% +8.91% vs SPY
  10. Sep 3, 202610w ago 8-K Neutral 2/10 Entry $6.89 to $6.03 Now $7.34 +6.53% ▼ −12.48% −13.08% vs SPY
Showing 10 of 22

US Market Status

Market Closed · Opens in 9h 7m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 3, 2026